4^th EHES Conference

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Register Now

EHES2024 Conference Fee

CATEGORY	LATE & ONSITE REGISTRATION FROM 01^st AUG
EHES/EMA Member	COMPLIMENTARY
Non Member/ Industry Professionals	AED 3122
Students	AED 1285
Government Entities	COMPLIMENTARY

Registration fee entitles participants to attend all the general and concurrent sessions, entrance to the exhibition, daily coffee breaks, daily lunch and conference materials
Registration fee for Industry Professionals includes a year membership to EMA
* For administrative purpose a copy of your ID is required as a proof in order to avail the registration fee for EMA Members and Students
* For EHES/EMA Members you are required to upload a valid membership ID of EMA to avail the registration fee.
CLICK HERE to apply as an EMA Member
**For Students the final confirmation along with the E-Badge will only be sent upon verification of the uploaded ID

Language: All abstracts are to be written in English. The Scientific Committee reserves the right to edit abstracts where the English structure makes comprehension difficult.

Submission: All abstracts must be uploaded via the Online Abstract Submission portal in pdf or word format. This should be limited to a maximum of 500 words and should include the following:

Title of Abstract
Names and contact details of author(s) {organization, city and country, email, phone numbers, and mailing address}. Please provide a 3-line biography of the author/s with your abstract (not included in the word limit).
The abstract must include the following headings clearly:
Background, Methods, Results and Discussion
(Please provide evidence of ethical approval and funding acknowledgements, if any)
Any graphs, charts, diagrams, photos or other forms of display of results can be uploaded separately
Abstract submission will be acknowledged via email. If you do not receive an email within two (2) weeks of submission or have any additional queries, please contact us by email at admin@ehes.ae
All abstracts must be submitted on or before 15th September

Scientific Topics are open to Value-Based and Healthcare Financing.

Abstracts must contain original scientific data collected by the author(s). All reports must be based on work that has already been completed. No studies “in progress” will be accepted. Any established research design or method may be used.

Selection Criteria

Abstracts will be evaluated through a blind review process and scored based upon the following criteria to be selected for Oral and Poster/E-Poster Presentations:

Originality
Concept and Design
Presentation
Clinical Applicability
Other Characteristics

Terms and Conditions

The scientific committee reserves the right to make the final decision about the abstract acceptance and its scheduling into the program, based on topics and time constraints.
The language of the Conference is English.
All abstracts must be prepared using the abstract submission guidelines.
Each presenter may submit a maximum of two abstracts.
Each abstract submission must indicate if the material was published or presented in any other Conference or if it received any awards.
All presenters must register to attend the Conference within a maximum of 1 week of acceptance of the abstract and be present at the time of the Conference.
A certificate of appreciation will be given to all the presenters to honour their presentation.
Presenters must not use the session as a marketing opportunity for products/equipment.
Conference registration charges will be waived off for accepted poster presenters only (for the Main Author only).
Payment for travel /accommodation/visa charges is not provided.

International Speakers

Prof Lieven Annemans

Economics of Health & Wellbeing
Faculty of Medicine & Health Sciences
Ghent University, Belgium
Prof Paul Kind

Honorary Professor
Department of Applied Health Research
Institute of Epidemiology and Health Care
University College London,
United Kingdom
Prof Panos Kanavos

PhD, Department of Health Policy
Programme Director, Medical Technologies
Deputy Director, LSE Health
London School of Economics,
United Kingdom
Prof Andrew Briggs

Professor of Health Economics Department of Health Services Research & Policy
London School of Hygiene & Tropical Medicine,
United Kingdom
Prof Tomasz Kluszczynski

Specialist in Health and Drug Policy
Patient Access Programme
Pricing and Reimbursement
HTA & HEOR, Value-Based Healthcare Vintura, Poland
Prof Zoltán Kaló

Professor of Health Economics
Center for Health Technology Assessment,
Semmelweis University,
CEO, Syreon Research Institute,
Hungary
Prof John Ataguba

Executive Director,
African Health Economics and Policy Association
Canada Research Chair in Health Economics
University of Manitoba, Canada
Prof Salah Ghabri

Scientific Referent in Health Economic Methodology & Evaluation
Department of Medical Evaluation
Direction of Evaluation & Access to Innovation
French National Authority for Health - HAS,
France
Dr Justus Wolff

Ph.D. Artificial Intelligence/ Life Sciences
Manager Digital Health Manager Digital Health, Syte,
Germany
Prof Steve Macfeely

Chief Statistician
Organisation for Economic Co-operation & Development (OECD),
France

Regional Speakers

Prof Dr Ahmed Aljedai

Pharm.D., M.B.A., BCPS, FCCP, FAST, FCCP, FASHP
Assistant Deputy Minister for Medical Support Services
Deputyship of Therapeutic Affairs
Ministry of Health, Riyadh, Saudi Arabia
Professor, Alfaisal University, Colleges of Medicine & Pharmacy
Consultant Clinical Pharmacist, Solid Organ Transplant, Saudi Arabia
Dr Anas Hamad

PhD, MSc, RPh
Director of Pharmacy, NCCCR
Head of Medication Safety Quality, HMC
Adjunct Assistant Professor, QU
Head of Medications Committee, QRCS,
Qatar
H.E. Shaikh Mohamed
Ebrahim Alkhalifa

Director of
Health Strategic Assessment Directorate
& Health Economics Program Manager,
Supreme Council of Health, Kingdom of Bahrain
Dr Hajer Almudaiheem

Director of Drug Policy & Regulation at
Deputyship of Therapeutic affairs
at Ministry of Health Saudi Arabia
Dr Suliman Alghnam

Executive Director of Surveillance,
Saudi Public Health Authority, KSA
ISPOR Arabic Network Executive Committee Chairman
Dr Yazeed Al Ruthia

Chief Executive Officer of Government Hospitals,
Bahrain
Dr Mariam Al Jalahma

Pharm.D., PhD
Associate Professor of Health Policy & Pharmacoeconomics,
Director of the Pharmacoeconomics Research Unit, College of Pharmacy,
King Saud University
Dr Sultana Al-Sabahi

MSc, PhD, Policy Analyst, Health Economist,
Evidence-informed Decision-Making Specialist,
Qualitative, Quantitative, and Mixed Method Researcher, HTA,
Project Manager, Ministry of Health, Sultanate of Oman
Dr Mohammed Alluhidan

Head of the Health Economics Unit (HEU)
Saudi Health Council, Saudi Arabia
Dr Abdullah Alibrahim

Assistant Professor of Industrial
& Management Systems Engineering
Kuwait University

Jumeirah Emirates Towers - 5 star

In a sleek skyscraper overlooking the city, this luxe hotel is 3 km from the Burj Khalifa. Sophisticated rooms and suites have free Wi-Fi, smart TVs, iPod docks and minibars. Suites add separate living areas; posh bi-level suites have whirlpool baths, floor-to-ceiling windows and/or butler service. Club quarters offer access to an exclusive lounge with breakfast (no charge). Room service is available. Freebies include an area shuttle, plus access to a private beach and an adjacent fitness centre. Dining options include chic international restaurants and trendy bars. There's an outdoor pool, a poolside bar, shops and a luxe spa.